Literature DB >> 2479774

Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions.

K Moelling1, T Schulze, H Diringer.   

Abstract

The reverse transcriptase (RT) activity of human immunodeficiency virus type 1 and other retroviruses is closely associated with a hybrid-degrading RNase H activity which is essential for retroviral replication. We have analyzed the effect of sulfated polysaccharides on human immunodeficiency virus type 1 recombinant RT and RNase H activities in vitro. Heparin, dextran sulfates, and xylan polysulfate were found to be much more potent inhibitors of RNase H than of RT and exhibit 50% infective doses of 0.04 to 0.1 micrograms/ml (corresponding to 0.1 to 25 nM) which is up to 5,000-fold more efficient than that for RT. Inhibitors of RNase H activity are attractive as antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479774      PMCID: PMC251222     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.

Authors:  R Friedrich; K Moelling
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine.

Authors:  R Ueno; S Kuno
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

3.  The role of Moloney murine leukemia virus RNase H activity in the formation of plus-strand primers.

Authors:  A J Rattray; J J Champoux
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus.

Authors:  J Hansen; T Schulze; K Moelling
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

5.  Effect of pentosan polysulfate (SP 54) on the reverse transcriptase activity of several retroviruses.

Authors:  G Sydow; H P Klöcking
Journal:  Biomed Biochim Acta       Date:  1987

6.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  The reticuloendothelial system in scrapie pathogenesis.

Authors:  B Ehlers; R Rudolph; H Diringer
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

8.  Mechanism of release of the avian rotavirus tRNATrp primer molecule from viral DNA by ribonuclease H during reverse transcription.

Authors:  C A Omer; A J Faras
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

9.  Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase.

Authors:  J J Champoux; E Gilboa; D Baltimore
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen.

Authors:  B Ehlers; H Diringer
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

View more
  12 in total

1.  Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.

Authors:  I W Althaus; R J LeMay; A J Gonzales; M R Deibel; S K Sharma; F J Kezdy; L Resnick; M E Busso; P A Aristoff; F Reusser
Journal:  Experientia       Date:  1992-12-01

2.  Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4.

Authors:  V Chams; T Idziorek; P J Maddon; D Klatzmann
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 3.  Transmissible spongiform encephalopathies (TSE) virus-induced amyloidoses of the central nervous system (CNS).

Authors:  H Diringer
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

4.  Sulfated polyanions do not inhibit duck hepatitis B virus infection.

Authors:  W B Offensperger; S Offensperger; E Walter; H E Blum; W Gerok
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 5.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 6.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

7.  The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.

Authors:  I W Althaus; K M Franks; K B Langley; F J Kézdy; T Peterson; S E Buxser; D E Decker; L A Dolak; R G Ulrich; F Reusser
Journal:  Experientia       Date:  1996-04-15

8.  RNase H activity associated with reverse transcriptase from feline immunodeficiency virus.

Authors:  R C Cronn; J D Whitmer; T W North
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells.

Authors:  B Caughey; G J Raymond
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Anti-viral activity of red microalgal polysaccharides against retroviruses.

Authors:  Marina M Talyshinsky; Yelena Y Souprun; Mahmoud M Huleihel
Journal:  Cancer Cell Int       Date:  2002-07-05       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.